Clinical Trial Update: --SuPERIOR Trial-- [Phase 2]

View source ↗

Summary

Phase 2 clinical trial for Non-Small Cell Lung Cancer was terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non-Small Cell Lung Cancer (NSCLC), Clinical Staging T2b-3 N0-1 M0 | Phase 2 | Status: TERMINATED